Advertisement

Immunodiagnostic Aspects of Autoantibodies Against Myeloperoxidase

  • Elena Csernok
  • Wolfgang L. Gross
Conference paper

Abstract

The past two decades have seen an explosion of data on the new group of autoantibodies known collectively as antineutrophil cytoplasmic antibodies (ANCA) which are specific for antigens in the cytoplasm (mainly primary granules) of neutrophils and monocytes. These autoantibodies were originally detected by indirect immunofluorescence (IIF) on alcohol-fixed neutrophils and two different staining patterns were described: the cytoplasmic (classic) cANCA and the perinuclear pANCA (Fig.25.1). cANCA is induced by autoantibodies directed against proteinase 3 (PR3) and pANCA is usually directed against myeloperoxidase (MPO) although other antigenic targets exist.

Keywords

Systemic Lupus Erythematosus Antineutrophil Cytoplasmic Antibody Crescentic Glomerulonephritis Rapidly Progressive Glomerulonephritis Idiopathic Systemic Vasculitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gross WL, Csernok E (1995) Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 7: 11–19PubMedGoogle Scholar
  2. 2.
    Hagen EC, Andrassy K, Csernok E, Daha MR, Gaskin G, Gross WL, Hansen B, Heigl Z, Hermans J, Jayne D, Kallenberg CGM, Lesavre Ph, Lockwood CM, Lüdemann J, Mascart-Lemone F, Mirapeix E, Pusey CD, Rasmussen N, Sinico RA, Tzioufas A, Wieslander J, Wiik A, Van der Woude FJ (1996) Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international study on the standardization of ANCA assays. J Immunol Methods 196: 1–15PubMedCrossRefGoogle Scholar
  3. 3.
    Wang G, Csernok E, Groot K de, Gross W (1997) Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA). Immunol Methods 208: 203–211CrossRefGoogle Scholar
  4. 4.
    Gueirard P, Delpech A, Gilbert D, et al (1991) Anti-myeloperoxidase antibodies: immunological characteristics and clinical associations. J Autoimmun 4: 517–527PubMedCrossRefGoogle Scholar
  5. 5.
    Ulmer M, Rautmann A, Gross WL (1992) Immunodiagnostic aspects of autoantibodies against myeloperoxidase. Clin Nephrol 37: 161–168PubMedGoogle Scholar
  6. 6.
    Hauschild S, Schmitt WH, Csernok E, Flesch BK, Rautmann A, Gross WL (1992) ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 336: 245–251Google Scholar
  7. 7.
    Braun MG, Csernok E, Schmitt WH, Gross WL (1996) Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 23: 826–830PubMedGoogle Scholar
  8. 8.
    Schnabel A, Csernok E, Isenberg DA, Mrowka C, Gross WL (1996) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Arthritis Rheum 38: 633–637CrossRefGoogle Scholar
  9. 9.
    Nässberger L, Sjöholm AG, Jonsson H, et al (1993) Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 81: 380–383CrossRefGoogle Scholar
  10. 10.
    Niles JL, Pan G, Collins AB, et al (1991) Antigen-specific radio-immunoassay for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. J Am Soc Nephrol 2: 27–36PubMedGoogle Scholar
  11. 11.
    Jayne DRW, Marshall PD, Jones SJ, Lockwood CM (1990) Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. Kidney Int 37: 965–970PubMedCrossRefGoogle Scholar
  12. 12.
    Gallichio MC, Savige JA (1991) Detection of antimyeloperoxidase and anti-elastase antibodies in vasculitis and infections. Clin Exp Immunol 84: 232–237CrossRefGoogle Scholar
  13. 13.
    Cohen-Tervaert JW, Goldschmeding R, Elema JD, et al (1990) Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum 33: 1264–1272CrossRefGoogle Scholar
  14. 14.
    Hagen EC, Daha MR, Hermann J, Andrassy K, Csernok E, Gaskin G, Lesavre P, Lüdemann J, Rasmussen N, Sinico RA, Wiik A, Woude F van der (1998) Diagnostic value of standardized assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int 53: 743–753PubMedCrossRefGoogle Scholar
  15. 15.
    Franssen C, Gans R, Kallenberg C, Hageluken C, Hoorntje S (1998) Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity. Distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 244: 209–216PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2000

Authors and Affiliations

  • Elena Csernok
  • Wolfgang L. Gross

There are no affiliations available

Personalised recommendations